Andrew E. Esch, MD, MBA
Andrew Esch is a palliative specialist and consultant focusing on improving the quality of life for patients and their families—through pain and symptom management, coordination of care, and education—as they face serious or life-threatening illness. Dr. Esch earned his medical degree from the University of Buffalo, where he also earned a combined bachelor of science and master of business administration degree. Currently he is a consultant and faculty member for the Center to Advance Palliative Care (CAPC). Prior to joining CAPC, Dr. Esch worked at the Lee Memorial Health System in Fort Myers, Florida, as medical director of palliative care. During his time there he was recognized with the prestigious Phoenix Award for his work with people with cancer. Dr. Esch speaks nationally on palliative care education and growth and sustainability of palliative care programs.
From the Blog
Defining palliative care, which patients need it, how it is delivered, and how palliative care differs from hospice.
Conducting a comprehensive pain assessment to guide safe and effective treatment.
Selecting a safe and appropriate analgesic for patients with serious illness based on the pain assessment.
Patient and family factors that influence prescribing decisions for patients with serious illness.
Integrating routine risk assessment for substance use disorder when considering or using opioid therapy.
Designing a safe and effective opioid trial for the patient with serious illness.
Safe and appropriate opioid prescribing for the opioid-naive patient with serious illness.
Four indications for using short-acting opioids.
Ongoing evaluation of opioid benefits, risks, and side effects for the patient with serious illness.
Guidance on safe conversion to long-acting opioids for patients with serious illness.
Prescribing practice for long half-life opioids, converting from one opioid to another, and accounting for incomplete cross-tolerance.
Changing the route of opioid delivery, rotating opioids, advanced opioid conversions, and tapering opioids.
Safe opioid prescribing in older adults, cognitively impaired patients, children, and the imminently dying, including patient-controlled analgesia.
Pain management for patients with serious illness and high risk for substance use disorder, including risk assessment, monitoring, and when to refer for safe pain management.
Safe opioid prescribing for patients with serious illness, using the Federation of State Medical Boards (FSMB) Guidelines for the Chronic Use of Opioid Analgesics.
Identifying and managing nausea and vomiting for patients living with serious illness and their caregivers.
Reducing physical and emotional suffering from dyspnea for patients with serious illness.
Assessing and managing constipation in people with serious illness.
Prevalence, screening recommendations, and evidence-based strategies to treat anxiety in patients with serious illness.
Prevalence, screening recommendations, and evidence-based strategies to treat depression in patients with serious illness.
Identifying and addressing the sources of suffering for patients and families living with dementia.
Assessing and addressing sources of suffering for people living with chronic obstructive pulmonary disease (COPD) and their caregivers.
Interventions to reduce suffering along the disease trajectory for people living with congestive heart failure (CHF) and their families.
Guidance for collaborating with treating providers to ensure that members who would benefit receive palliative care.
Communication and assessment techniques for case managers to elicit goals of care and address suffering for people with serious illness.
The role of the direct care worker in observing and reporting suffering in patients with serious illness.